Literature DB >> 2409350

Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study.

A D Snow, R Kisilevsky.   

Abstract

The temporal relationship between glycosaminoglycan (GAG) accumulation and amyloid deposition was determined in two models of amyloid induction. In the first model amyloid was induced rapidly using amyloid-enhancing factor and AgNO3 as an inflammatory stimulus. In the second model amyloid was induced by daily injections of azocasein. Congo red staining was used to demonstrate amyloid, and both the sulfated Alcian blue and Alcian blue (pH 5.7)-MgCl2 methods were used to demonstrate GAGs. In the rapid model, amyloid was first detected in the splenic perifollicular areas 36 hours after induction. The initial presence of GAGs was also seen at 36 hours and in the exact locale where the amyloid was found. Amyloid was first seen in the liver about the central veins at 48 hours. GAGs in the liver appeared coincidentally with and in the same location as the amyloid. In the traditional model (azocasein injections) amyloid did not appear in the spleen until day 6 to 7, again with coincidental GAG deposition. The present study shows that amyloid-associated GAGs appear in the tissues together with the AA protein and are not a function of the tissue type. The appearance of the GAGs is also not a function of the nature of the inflammatory agent or its length of action but appears to be part of the process involved in the deposition of the AA protein.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409350

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  40 in total

Review 1.  Amyloidosis.

Authors:  M F Khan; R H Falk
Journal:  Postgrad Med J       Date:  2001-11       Impact factor: 2.401

2.  The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein.

Authors:  Richard W McLaughlin; Janelle K De Stigter; Laura A Sikkink; Elizabeth M Baden; Marina Ramirez-Alvarado
Journal:  Protein Sci       Date:  2006-06-02       Impact factor: 6.725

3.  In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.

Authors:  Jin-Ping Li; Martha L Escobar Galvis; Feng Gong; Xiao Zhang; Eyal Zcharia; Shula Metzger; Israel Vlodavsky; Robert Kisilevsky; Ulf Lindahl
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-20       Impact factor: 11.205

Review 4.  Sulfated glycosaminoglycans in protein aggregation diseases.

Authors:  Kazuchika Nishitsuji; Kenji Uchimura
Journal:  Glycoconj J       Date:  2017-04-11       Impact factor: 2.916

5.  Role of glycosaminoglycan sulfation in the formation of immunoglobulin light chain amyloid oligomers and fibrils.

Authors:  Ruiyi Ren; Zhenning Hong; Haiyan Gong; Kate Laporte; Martha Skinner; David C Seldin; Catherine E Costello; Lawreen H Connors; Vickery Trinkaus-Randall
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

6.  Salts enhance both protein stability and amyloid formation of an immunoglobulin light chain.

Authors:  Laura A Sikkink; Marina Ramirez-Alvarado
Journal:  Biophys Chem       Date:  2008-03-18       Impact factor: 2.352

7.  Lardaceous disease: some early reports by British authors (1722-1879).

Authors:  L Doyle
Journal:  J R Soc Med       Date:  1988-12       Impact factor: 5.344

8.  Influence of the carboxy terminus of serum amyloid A on protein oligomerization, misfolding, and fibril formation.

Authors:  Sanket Patke; Ronak Maheshwari; Jeffrey Litt; Saipraveen Srinivasan; J Javier Aguilera; Wilfredo Colón; Ravi S Kane
Journal:  Biochemistry       Date:  2012-03-26       Impact factor: 3.162

Review 9.  The role of novel chitin-like polysaccharides in Alzheimer disease.

Authors:  Rudy J Castellani; George Perry; Mark A Smith
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

10.  Proteoglycans in haemodialysis-related amyloidosis.

Authors:  K Ohashi; M Hara; M Yanagishita; R Kawai; S Tachibana; Y Ogura
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.